Points of Concern Related to the Micafungin versus Caspofungin Trial

Rotstein, Coleman
Pappas, Peter G.
Betts, Robert F.
Buell, Donald N.
Wu, Chunzgang

¹McMaster University, Hamilton, Onatario, Canada;
²Hamilton Health Sciences, Hamilton, Onatario, Canada;
³University of Alabama, Birmingham
⁴University of Rochester, New York;
⁵Astellas Pharma US, Deerfield, Illinois

Reprints or correspondence: Dr. Coleman Rotstein, University Health Network, Toronto General Hospital, NCSB 11-1212, 200 Elizabeth St., Toronto, Ontario M5G 2C4, Canada ([email protected]).

Clinical Infectious Diseases 46(4):p 641, February 15, 2008. | DOI: 10.1086/527037